Please login to the form below

EuBiologics

This page shows the latest EuBiologics news and features for those working in and with pharma, biotech and healthcare.

FDA approves first cholera vaccine in US

The WHO approved a third supplier of oral cholera vaccines - South Korea's EuBiologics - last December in a move designed to double production output to 6m doses a year.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Account Manager / Account Director: Competative

Principal Health Economist - North-West: Negotiable

Account Director: Competitive Salary Offered

Business Development Director – Health Education: excellent commission

Associate Director: £75, 000-90, 000

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Medical Writer: Salary TBC

Systematic Reviewer - Oxford: Negotiable

Associate Medical Director: Excellent PTO, bonus and 401k package

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Medical (Scientific) Director: £120, 000 benefits

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Editorial Manager - MedComms: DOE

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Experienced Medical Writers: Competitive Salary and Benefits

Business Director: Competitive Salary Offered

Account Executive/ Senior Account Executive: competitive Salary Offfered

Account Manager: Negotiable

Senior Account Manager: Competitive Salary Offered

Healthcare Communications Account Directors x 2: Salary TBC

Senior Editorial Assistant – Greater Manchester: DOE

Account Director – Healthcare Marketing – Berks: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Is China ready for a pharmaceutical gold rush?: Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...